增强免疫组化和原位杂交方法检测非小细胞肺癌的ALK重排的临床可行性

BACKGROUND AND OBJECTIVE: Besides epidermal growth factor receptor (EGFR) mutation, the non-small cell lung cancer (NSCLC) of anaplastic lymphoma kinase (ALK) rearrangement becomes another important clinical subtype. A specific and high-sensitive and economical detection way is convenience for ident...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2015
Materias:
Alk阳性nsclc诊治
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999847/
https://www.ncbi.nlm.nih.gov/pubmed/25676399
http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999847/
https://www.ncbi.nlm.nih.gov/pubmed/25676399
http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.04

Ejemplares similares